Shionogi Funding Research to Develop World’s First Drug for Preventing Postoperative Metastasis of Lung Cancer

Clinical research investigating whether the atrial natriuretic peptide (ANP) could become the world’s first “anti-metastatic agent” for preventing relapse and metastasis following lung cancer surgery, is moving forward at the National Cerebral and Cardiovascular Center (NCVC) and other facilities. Joint...read more